What is Pharmaligent?
Pharmaligent specializes in providing comprehensive quality and compliance services tailored for the pharmaceutical, medical device, and biologics industries. Their expertise encompasses the development of robust quality systems, meticulous risk assessments, and effective resolution of FDA-related issues. With over two decades of operational experience, Pharmaligent's dedicated team delivers customized solutions designed to enhance client productivity and ensure stringent adherence to global regulatory standards across the United States, Europe, Asia, and Africa. Their commitment lies in offering expert guidance to navigate the intricate landscape of drug and device development.
How much funding has Pharmaligent raised?
Pharmaligent has raised a total of $23K across 1 funding round:
Debt
$23K
Debt (2021): $23K with participation from PPP
What's next for Pharmaligent?
The recent influx of substantial expansion capital positions Pharmaligent for accelerated growth and enhanced service delivery. This strategic investment is expected to fuel the company's efforts in broadening its market reach and deepening its service offerings within the critical areas of pharmaceutical and medical device quality assurance and regulatory compliance. As Pharmaligent continues to support clients in navigating complex regulatory environments, this financing will likely enable further innovation and operational scaling to meet evolving industry demands.
See full Pharmaligent company page
